Crossing the Rubicon: when pancreatic resection with curative intent ends in an R2 status. Impact of "desmoplastic pseudo-pancreatitis" and anatomical site of irresectability.

Standard

Crossing the Rubicon: when pancreatic resection with curative intent ends in an R2 status. Impact of "desmoplastic pseudo-pancreatitis" and anatomical site of irresectability. / Bockhorn, Maximilian; Cataldegirmen, Güllü; Kutup, Asad; Marx, Andreas; Burdelski, Christoph; Vashist, Yogesh; Mann, Oliver; Deutsch, Lena; König, Alexandra; Izbicki, Jakob R.; Yekebas, Emre F.

in: ANN SURG ONCOL, Jahrgang 16, Nr. 5, 5, 01.05.2009, S. 1212-1221.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Bockhorn, M, Cataldegirmen, G, Kutup, A, Marx, A, Burdelski, C, Vashist, Y, Mann, O, Deutsch, L, König, A, Izbicki, JR & Yekebas, EF 2009, 'Crossing the Rubicon: when pancreatic resection with curative intent ends in an R2 status. Impact of "desmoplastic pseudo-pancreatitis" and anatomical site of irresectability.', ANN SURG ONCOL, Jg. 16, Nr. 5, 5, S. 1212-1221. https://doi.org/10.1245/s10434-009-0363-2

APA

Bockhorn, M., Cataldegirmen, G., Kutup, A., Marx, A., Burdelski, C., Vashist, Y., Mann, O., Deutsch, L., König, A., Izbicki, J. R., & Yekebas, E. F. (2009). Crossing the Rubicon: when pancreatic resection with curative intent ends in an R2 status. Impact of "desmoplastic pseudo-pancreatitis" and anatomical site of irresectability. ANN SURG ONCOL, 16(5), 1212-1221. [5]. https://doi.org/10.1245/s10434-009-0363-2

Vancouver

Bibtex

@article{810b0ceed0b547939c79ae498df6c8e6,
title = "Crossing the Rubicon: when pancreatic resection with curative intent ends in an R2 status. Impact of {"}desmoplastic pseudo-pancreatitis{"} and anatomical site of irresectability.",
abstract = "AIM: To analyze the impact of pancreatitis-mimicking, concomitant alterations on intraoperative assessment of curative resectability, the anatomical site of irresectability, and outcome after nonintentional R2 resection in pancreatic cancer. METHODS: Of 1,099 patients subjected to pancreatic resection for cancer, 40 (4%) underwent R2 resection (group A). The site where tumors turned out to be irresectable and the coincident presence of potentially misleading, fibro-desmoplastic alterations were analyzed. Outcome after resection was compared with 40 bypass patients matched for age, gender, histopathology, and use of additive chemotherapy (group B). RESULTS: R2 resection was due to misjudgment regarding resectability in 38 patients (95%) and to uncontrollable hemorrhage in 2 patients (5%). Group A patients had significantly longer operative times (P <0.0001), required more blood units (P <0.0001), and had longer hospital stay than group B patients (P = 0.049). Despite a significantly higher relaparotomy rate of 20% (n = 8) in group A versus 5% (n = 2) in group B, perioperative mortality was equal (n = 2, each). Median survival was 11.5 months in group A and 7.5 months in group B (P = 0.014). {"}Pancreatitis-like{"} lesions were assessed in 70% (n = 28/40, group A) and 25% (10/40, group B; P = 0.014). The superior mesenteric artery proximal to its jejunal branches was the most likely site of irresectability (60%), followed by its peripheral course (22.5%) and the lower aspects of the celiac trunk (17.5%). CONCLUSIONS: Concomitant {"}pancreatitis-like{"} alterations hamper the assessment of local resectability in pancreatic cancer. Although palliative resection results in elevated perioperative morbidity compared with bypass procedures, mortality is equal, while survival is prolonged.",
keywords = "Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Neoplasm Staging, Pancreatectomy, Pancreatic Neoplasms",
author = "Maximilian Bockhorn and G{\"u}ll{\"u} Cataldegirmen and Asad Kutup and Andreas Marx and Christoph Burdelski and Yogesh Vashist and Oliver Mann and Lena Deutsch and Alexandra K{\"o}nig and Izbicki, {Jakob R.} and Yekebas, {Emre F.}",
year = "2009",
month = may,
day = "1",
doi = "10.1245/s10434-009-0363-2",
language = "English",
volume = "16",
pages = "1212--1221",
journal = "ANN SURG ONCOL",
issn = "1068-9265",
publisher = "Springer New York",
number = "5",

}

RIS

TY - JOUR

T1 - Crossing the Rubicon: when pancreatic resection with curative intent ends in an R2 status. Impact of "desmoplastic pseudo-pancreatitis" and anatomical site of irresectability.

AU - Bockhorn, Maximilian

AU - Cataldegirmen, Güllü

AU - Kutup, Asad

AU - Marx, Andreas

AU - Burdelski, Christoph

AU - Vashist, Yogesh

AU - Mann, Oliver

AU - Deutsch, Lena

AU - König, Alexandra

AU - Izbicki, Jakob R.

AU - Yekebas, Emre F.

PY - 2009/5/1

Y1 - 2009/5/1

N2 - AIM: To analyze the impact of pancreatitis-mimicking, concomitant alterations on intraoperative assessment of curative resectability, the anatomical site of irresectability, and outcome after nonintentional R2 resection in pancreatic cancer. METHODS: Of 1,099 patients subjected to pancreatic resection for cancer, 40 (4%) underwent R2 resection (group A). The site where tumors turned out to be irresectable and the coincident presence of potentially misleading, fibro-desmoplastic alterations were analyzed. Outcome after resection was compared with 40 bypass patients matched for age, gender, histopathology, and use of additive chemotherapy (group B). RESULTS: R2 resection was due to misjudgment regarding resectability in 38 patients (95%) and to uncontrollable hemorrhage in 2 patients (5%). Group A patients had significantly longer operative times (P <0.0001), required more blood units (P <0.0001), and had longer hospital stay than group B patients (P = 0.049). Despite a significantly higher relaparotomy rate of 20% (n = 8) in group A versus 5% (n = 2) in group B, perioperative mortality was equal (n = 2, each). Median survival was 11.5 months in group A and 7.5 months in group B (P = 0.014). "Pancreatitis-like" lesions were assessed in 70% (n = 28/40, group A) and 25% (10/40, group B; P = 0.014). The superior mesenteric artery proximal to its jejunal branches was the most likely site of irresectability (60%), followed by its peripheral course (22.5%) and the lower aspects of the celiac trunk (17.5%). CONCLUSIONS: Concomitant "pancreatitis-like" alterations hamper the assessment of local resectability in pancreatic cancer. Although palliative resection results in elevated perioperative morbidity compared with bypass procedures, mortality is equal, while survival is prolonged.

AB - AIM: To analyze the impact of pancreatitis-mimicking, concomitant alterations on intraoperative assessment of curative resectability, the anatomical site of irresectability, and outcome after nonintentional R2 resection in pancreatic cancer. METHODS: Of 1,099 patients subjected to pancreatic resection for cancer, 40 (4%) underwent R2 resection (group A). The site where tumors turned out to be irresectable and the coincident presence of potentially misleading, fibro-desmoplastic alterations were analyzed. Outcome after resection was compared with 40 bypass patients matched for age, gender, histopathology, and use of additive chemotherapy (group B). RESULTS: R2 resection was due to misjudgment regarding resectability in 38 patients (95%) and to uncontrollable hemorrhage in 2 patients (5%). Group A patients had significantly longer operative times (P <0.0001), required more blood units (P <0.0001), and had longer hospital stay than group B patients (P = 0.049). Despite a significantly higher relaparotomy rate of 20% (n = 8) in group A versus 5% (n = 2) in group B, perioperative mortality was equal (n = 2, each). Median survival was 11.5 months in group A and 7.5 months in group B (P = 0.014). "Pancreatitis-like" lesions were assessed in 70% (n = 28/40, group A) and 25% (10/40, group B; P = 0.014). The superior mesenteric artery proximal to its jejunal branches was the most likely site of irresectability (60%), followed by its peripheral course (22.5%) and the lower aspects of the celiac trunk (17.5%). CONCLUSIONS: Concomitant "pancreatitis-like" alterations hamper the assessment of local resectability in pancreatic cancer. Although palliative resection results in elevated perioperative morbidity compared with bypass procedures, mortality is equal, while survival is prolonged.

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Neoplasm Staging

KW - Pancreatectomy

KW - Pancreatic Neoplasms

U2 - 10.1245/s10434-009-0363-2

DO - 10.1245/s10434-009-0363-2

M3 - SCORING: Journal article

C2 - 19225843

VL - 16

SP - 1212

EP - 1221

JO - ANN SURG ONCOL

JF - ANN SURG ONCOL

SN - 1068-9265

IS - 5

M1 - 5

ER -